Organization Overview
Alternative names
abobotulinumtoxinA (Dysport) (2 trials)
acetaminophen (tylenol) (1 trial)
acetylsalicylic acid (aspirin) (4 trials)
alteplase (Activase) (1 trial)
asparaginase (elspar) (1 trial)
azathioprine (imuran) (2 trials)
azithromycin (zithromax) (3 trials)
bacille calmette-guerin (1 trial)
baricitinib (olumiant) (1 trial)
belimumab (benlysta) (3 trials)
benzathine penicillin (1 trial)
bevacizumab (avastin) (3 trials)
bezafibrate (Bezalip) (1 trial)
bnt162b2 (Comirnaty) (4 trials)
bone marrow derived mesenchymal stem cells (1 trial)
budesonide (rhinocort) (1 trial)
capecitabine (xeloda) (1 trial)
cisplatin (platinol) (1 trial)
clopidogrel (plavix) (2 trials)
clorazepate (tranxene) (1 trial)
cobimetinib (cotellic) (1 trial)
dexchlorpheniramine maleate (polaramine) (1 trial)
doxycycline (vibramycin) (1 trial)
ethambutol (myambutol) (1 trial)
fludrocortisone (florinef) (1 trial)
fluorouracil (efudex) (6 trials)
fluticasone (cutivate) (1 trial)
formoterol (foradil) (1 trial)
gallium-68-dotatate (netspot) (1 trial)
gemcitabine (gemzar) (6 trials)
gentamicin (garamycin) (3 trials)
haploidentical mononuclear cells (1 trial)
human fecal microbiota (Reybota) (4 trials)
human papillomavirus 9-valent vaccine, recombinant (Gardasil 9) (1 trial)
hydrocortisone (solu-cortef) (2 trials)
hydroxychloroquine (plaquenil) (6 trials)
hydroxyurea (hydrea) (1 trial)
immune globulin (human) (Gamastan) (4 trials)
inactivated influenza vaccine (1 trial)
infliximab (remicade) (3 trials)
insulin human (humulin) (2 trials)
interferon alpha-2b (Intron-A) (1 trial)
irinotecan (Camptosar) (2 trials)
isavuconazonium (cresemba) (1 trial)
isoniazid (nydrazid) (1 trial)
lenalidomide (revlimid) (2 trials)
letermovir (prevymis) (2 trials)
levocetirizine (xyzal) (1 trial)
macitentan (opsumit) (1 trial)
magnesium sulfate (Tis-U-Sol) (1 trial)
mepolizumab (Nucala) (1 trial)
metformin (glucophage) (2 trials)
methylphenidate (ritalin) (1 trial)
methylprednisolone (medrol) (5 trials)
metoclopramide (reglan) (1 trial)
mrna-1273 (Spikevax) (3 trials)
mycophenolate (CellCept) (2 trials)
nicotine (nicorette) (3 trials)
nifedipine (procardia) (1 trial)
obinutuzumab (gazyva) (1 trial)
ocrelizumab (ocrevus) (1 trial)
onabotulinumtoxinA (Botox) (3 trials)
pentoxifylline (trental) (1 trial)
perampanel (fycompa) (1 trial)
piperacillin (pipracil) (1 trial)
potassium chloride (klor-con) (2 trials)
prednisolone (hydeltra) (1 trial)
prilocaine (citanest) (1 trial)
pyrazinamide (Aldinamide) (1 trial)
rituximab (rituxan) (7 trials)
sacubitril (Entresto) (2 trials)
salmeterol (serevent) (1 trial)
sarilumab (kevzara) (2 trials)
serogroup b meningococcal vaccine (Trumenba) (1 trial)
serogroup B meningococcal vaccine (Bexsero) (1 trial)
sevoflurane (ultane) (1 trial)
tacrolimus (prograf) (2 trials)
terlipressin (Terlivaz) (1 trial)
ticagrelor (brilinta) (2 trials)
tocilizumab (actemra) (7 trials)
tranexamic acid (cyklokapron) (1 trial)
valaciclovir (Valtrex) (1 trial)
23-valent pneumococcal polysaccharide vaccine (pneumovax-23) (1 trial)
99mtc-rhannexin v-128 (1 trial)
abatacept (orencia) (2 trials)
abiraterone (zytiga) (1 trial)
adalimumab (humira) (2 trials)
aldesleukin (Proleukin) (6 trials)
allogeneic adipose derived mesenchymal stem cell (2 trials)
allogeneic hematopoietic stem cells (Hemacord) (3 trials)
allopurinol (zyloprim) (1 trial)
autologous hematopoietic cells transduced with a lentiviral vector with dclre1c (1 trial)
autologous mesenchymal stem cells (1 trial)
azacitidine (vidaza) (1 trial)
binimetinib (mektovi) (1 trial)
blinatumomab (blincyto) (1 trial)
capmatinib (Tabrecta) (1 trial)
COVID-19 convalescent plasma (1 trial)
cyclosporine (sandimmune) (2 trials)
dapagliflozin (farxiga) (1 trial)
degarelix acetate (firmagon) (1 trial)
dimethyl fumarate (tecfidera) (1 trial)
durvalumab (imfinzi) (1 trial)
eculizumab (Soliris) (1 trial)
elotuzumab (empliciti) (1 trial)
emtricitabine (emtriva) (1 trial)
encorafenib (braftovi) (1 trial)
enfuvirtide (fuzeon) (1 trial)
erwinia asparaginase (Erwinaze) (1 trial)
everolimus (zortress) (1 trial)
flucytosine (ancobon) (1 trial)
fludarabine (fludara) (1 trial)
fulvestrant (faslodex) (1 trial)
haplo-identical hematopoietic stem cells (1 trial)
Isatuximab (Sarclisa) (2 trials)
lenvatinib (lenvima) (1 trial)
mepivacaine (carbocaine) (1 trial)
palbociclib (ibrance) (1 trial)
panitumumab (vectibix) (1 trial)
pembrolizumab (keytruda) (1 trial)
pirfenidone (esbriet) (1 trial)
pneumococcal 13-valent conjugate vaccine (prevnar 13) (1 trial)
sargramostim (leukine) (1 trial)
secukinumab (cosentyx) (1 trial)
selumetinib (Koselugo) (1 trial)
sheep derived polyvalent antihuman-immunoglobulin coupled to sepharosetm cl-4b (1 trial)
sirolimus (rapamune) (1 trial)
somatropin (protropin) (1 trial)
sulfasalazine (azulfidine) (1 trial)
talimogene laherparepvec (Imlygic) (1 trial)
tedizolid phosphate (sivextro) (1 trial)
temozolomide (temodar) (2 trials)
tinzaparin (Innohep) (2 trials)
umbilical cord mesenchymal stem cells (1 trial)
unfractionated heparin (1 trial)
Abortion, Habitual (Phase 2)
Abortion, Spontaneous (Phase 2)
Acute Kidney Injury (Phase 4)
Acute Lung Injury (Phase 3)
Adenocarcinoma (Phase 3)
Alzheimer Disease (Phase 3)
Anemia, Hemolytic (Phase 2)
Anemia, Hemolytic, Autoimmune (Phase 2)
Anemia, Sickle Cell (Phase 2)
Angioedema (Phase 3)
Antiphospholipid Syndrome (Phase 2)
Aortic Arch Syndromes (Phase 2)
Arteriosclerosis (Phase 3)
Arteritis (Phase 2)
Arthritis, Gouty (Phase 4)
Ataxia (Phase 3)
Atherosclerosis (Phase 3)
Atrial Fibrillation (Phase 3)
Atrophy (Phase 2)
Autism Spectrum Disorder (Phase 3)
Autistic Disorder (Phase 3)
Autoimmune Diseases (Phase 2)
Behcet Syndrome (Phase 3)
Bipolar Disorder (Phase 2)
Brain Neoplasms (Phase 2)
Breast Neoplasms (Phase 2)
Bronchiolitis (Phase 3)
Bronchiolitis Obliterans (Phase 3)
Calcinosis (Phase 3)
Calculi (Phase 3)
Carcinoma (Phase 2)
Carcinoma, Adenoid Cystic (Phase 2)
Carcinoma, Ductal, Breast (Phase 2)
Carcinoma, Hepatocellular (Phase 2)
Cardiomyopathies (Phase 3)
Cardiomyopathy, Hypertrophic (Phase 3)
Carotid Artery Diseases (Phase 3)
Cerebellar Ataxia (Phase 3)
Child Development Disorders, Pervasive (Phase 3)
Cholangitis (Phase 3)
Cholangitis, Sclerosing (Phase 3)
Cholestasis (Phase 3)
Colitis (Phase 3)
Colitis, Ulcerative (Phase 3)
Colonic Neoplasms (Phase 3)
Colorectal Neoplasms (Phase 2)
Communicable Diseases (Phase 3)
Condylomata Acuminata (Phase 3)
Constriction, Pathologic (Phase 2)
Coronary Artery Disease (Phase 3)
Coronaviridae Infections (Phase 2)
Coronavirus Infections (Phase 3)
Critical Illness (Phase 3)
Cryoglobulinemia (Phase 2)
Dehydration (Phase 3)
Delirium (Phase 3)
Diabetes, Gestational (Phase 3)
Diabetes Mellitus (Phase 3)
Diabetes Mellitus, Type 1 (Phase 3)
Disease Progression (Phase 2)
Dyspnea (Phase 2)
Embolism (Phase 3)
Emergencies (Phase 3)
Encephalitis (Phase 2)
Esophageal Stenosis (Phase 2)
Familial Hypophosphatemic Rickets (Phase 4)
Fetal Membranes, Premature Rupture (Phase 3)
Fibrosis (Phase 3)
Fractures, Bone (Phase 3)
Friedreich Ataxia (Phase 2)
Geographic Atrophy (Phase 2)
Glioblastoma (Phase 2)
Glioma (Phase 2)
Gout (Phase 4)
Graft vs Host Disease (Phase 3)
Head and Neck Neoplasms (Phase 2)
Heart Arrest (Phase 2)
Hemorrhage (Phase 3)
Hepatic Insufficiency (Phase 3)
Histiocytosis (Phase 3)
HIV Infections (Phase 2)
Hyperkalemia (Phase 4)
Hyperkinesis (Phase 3)
Hypersensitivity (Phase 2)
Hypertension (Phase 3)
Hypertension, Portal (Phase 3)
Hypertrophy (Phase 3)
Hypophosphatemia (Phase 4)
Infections (Phase 3)
Iridocyclitis (Phase 3)
Kidney Tubular Necrosis, Acute (Phase 4)
Leukemia (Phase 3)
Leukemia, Lymphoid (Phase 2)
Leukoencephalopathies (Phase 2)
Liver Cirrhosis (Phase 3)
Liver Failure (Phase 3)
Liver Neoplasms (Phase 2)
Lung Diseases (Phase 3)
Lung Diseases, Interstitial (Phase 3)
Lupus Erythematosus, Systemic (Phase 2)
Lymphoma (Phase 2)
Lymphoma, B-Cell (Phase 2)
Lymphoma, Large B-Cell, Diffuse (Phase 2)
Macular Degeneration (Phase 2)
Marijuana Abuse (Phase 3)
Mastocytosis (Phase 3)
Mastocytosis, Systemic (Phase 3)
Melanoma (Phase 2)
Microscopic Polyangiitis (Phase 3)
Mucocutaneous Lymph Node Syndrome (Phase 3)
Multiple Myeloma (Phase 3)
Multiple Sclerosis (Phase 3)
Multiple Sclerosis, Chronic Progressive (Phase 3)
Myelodysplastic Syndromes (Phase 3)
Myocardial Ischemia (Phase 3)
Myositis (Phase 3)
Necrosis (Phase 4)
Neoplasm Metastasis (Phase 3)
Neoplasms, Plasma Cell (Phase 3)
Neoplasms, Second Primary (Phase 2)
Nephrosis (Phase 3)
Nephrosis, Lipoid (Phase 2)
Nephrotic Syndrome (Phase 3)
Nidovirales Infections (Phase 2)
Osteoporosis (Phase 3)
Out-of-Hospital Cardiac Arrest (Phase 2)
Pancreatic Neoplasms (Phase 3)
Plaque, Atherosclerotic (Phase 3)
Pneumonia (Phase 3)
Polycythemia (Phase 3)
Polycythemia Vera (Phase 3)
Pregnancy in Diabetics (Phase 3)
Premature Birth (Phase 3)
Prostatic Neoplasms (Phase 2)
Pulmonary Alveolar Proteinosis (Phase 2)
Pulmonary Embolism (Phase 3)
Pulmonary Fibrosis (Phase 3)
Purpura (Phase 3)
Purpura, Thrombocytopenic (Phase 3)
Purpura, Thrombocytopenic, Idiopathic (Phase 2)
Purpura, Thrombotic Thrombocytopenic (Phase 3)
Pyelonephritis (Phase 4)
Rare Diseases (Phase 4)
Raynaud Disease (Phase 3)
Rectal Neoplasms (Phase 3)
Recurrence (Phase 3)
Respiration Disorders (Phase 3)
Respiratory Distress Syndrome (Phase 3)
Respiratory Distress Syndrome, Newborn (Phase 3)
Respiratory Insufficiency (Phase 3)
Respiratory Tract Diseases (Phase 3)
Respiratory Tract Infections (Phase 2)
Rickets (Phase 2)
Rickets, Hypophosphatemic (Phase 2)
RNA Virus Infections (Phase 2)
Rupture (Phase 3)
Sarcoidosis (Phase 3)
Sarcoma (Phase 2)
Sarcoma, Kaposi (Phase 2)
Scleroderma, Diffuse (Phase 3)
Scleroderma, Systemic (Phase 3)
Sclerosis (Phase 3)
Severe Acute Respiratory Syndrome (Phase 3)
Severe Combined Immunodeficiency (Phase 2)
Shock (Phase 3)
Shock, Septic (Phase 3)
Short Bowel Syndrome (Phase 4)
Sjogren's Syndrome (Phase 2)
Spinocerebellar Ataxias (Phase 3)
Spinocerebellar Degenerations (Phase 3)
Status Epilepticus (Phase 3)
Stroke (Phase 1)
Syndrome (Phase 4)
Systemic Vasculitis (Phase 3)
Takayasu Arteritis (Phase 2)
Tennis Elbow (Phase 3)
Thrombocythemia, Essential (Phase 3)
Thrombocytopenia (Phase 2)
Thrombocytosis (Phase 3)
Thrombosis (Phase 3)
Trigeminal Nerve Diseases (Phase 3)
Trigeminal Nerve Injuries (Phase 3)
Ulcer (Phase 3)
Urinary Tract Infections (Phase 3)
Urolithiasis (Phase 3)
Urticaria (Phase 3)
Uveitis (Phase 3)
Uveitis, Anterior (Phase 3)
Vasculitis (Phase 3)
Ventricular Fibrillation (Phase 2)
Virus Diseases (Phase 3)
Warts (Phase 3)
Wounds and Injuries (Phase 3)